SCHEMBL3537647

SCHEMBL3537647

CN1C(=O)C(c2ccc(OC(F)(F)F)cc2)(c2cccc(-c3cccnc3)c2)N=C1N

nearest known ligand 0.75

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.75
BACE2 Q9Y5Z0 17/20 0.75
CTSD P07339 15/20 0.75
REN P00797 2/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3539222 0.88 BACE1 (0.87) BACE1BACE2CTSDREN
SCHEMBL8240478 0.87 BACE1 (0.80) BACE1BACE2CTSD
SCHEMBL3533665 0.87 BACE1 (0.78) BACE1BACE2CTSDREN
SCHEMBL4232691 0.86 BACE1 (1.00) BACE1BACE2CTSDREN
SCHEMBL4312382 0.85 BACE1 (1.00) BACE1BACE2CTSD
SCHEMBL14109888 0.85 BACE1 (0.82) BACE1BACE2CTSDREN
SCHEMBL4517640 0.85 BACE1 (0.74) BACE1BACE2CTSDREN
SCHEMBL4531720 0.85 BACE1 (0.74) BACE1BACE2CTSDREN
SCHEMBL4526433 0.85 BACE1 (0.74) BACE1BACE2CTSDREN
SCHEMBL4318953 0.85 BACE1 (1.00) BACE1BACE2CTSDREN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756087-B1 AMINO-5,5-DIPHENYLIMIDAZOLONE DERIVATIVES FOR THE INHIBITION OF BETA-SECRETASE WYETH CORP (US) 2009-10-07 EP claimed
US-20090093498-A1 AMINO-5,5-DIPHENYLIMIDAZOLONE DERIVATIVES FOR THE INHIBITION OF BETA-SECRETASE WYETH (US) 2009-04-09 US claimed
US-7482349-B2 Amino-5,5-diphenylimidazolone derivatives for the inhibition of β-secretase WYETH (US) 2009-01-27 US claimed
CN-1968945-A Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase WYETH CORP (US) 2007-05-23 CN claimed
US-20050282825-A1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase WYETH (US) 2005-12-22 US claimed
US-7700602-B2 Amino-5,5-diphenylimidazolone derivatives for the inhibition of β-secretase WYETH LLC (US) 2010-04-20 US disclosed
EP-1756087-B1 AMINO-5,5-DIPHENYLIMIDAZOLONE DERIVATIVES FOR THE INHIBITION OF BETA-SECRETASE WYETH CORP (US) 2009-10-07 EP disclosed
US-20090093498-A1 AMINO-5,5-DIPHENYLIMIDAZOLONE DERIVATIVES FOR THE INHIBITION OF BETA-SECRETASE WYETH (US) 2009-04-09 US disclosed
US-7482349-B2 Amino-5,5-diphenylimidazolone derivatives for the inhibition of β-secretase WYETH (US) 2009-01-27 US disclosed
CN-1968945-A Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase WYETH CORP (US) 2007-05-23 CN disclosed
US-20050282825-A1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase WYETH (US) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093498-A1 AMINO-5,5-DIPHENYLIMIDAZOLONE DERIVATIVES FOR THE INHIBITION OF BETA-SECRETASE BACE1, BACE2, APP BACE1 1/4885BACE2 2/4885CTSD 158/4885
US-20050282825-A1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase BACE1, BACE2, APP BACE1 1/4885BACE2 2/4885CTSD 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.